BioCentury | Aug 15, 2016
Finance

Serving returns

...triglycerides. While Ally Bridge's bets in AD and diabetes focus on single assets, portfolio company Symic Biomedical Inc....
...Roche (SIX:ROG; OTCQX:RHHBY), Basel, Switzerland Servier, Neuilly-sur-Seine, France Sorrento Therapeutics Inc. (NASDAQ:SRNE), San Diego, Calif. Symic Biomedical Inc....
...Pieris Pharmaceuticals Inc. (NASDAQ:PIRS) PRS-080, a first-in-class anticalin hepcidin antagonist to treat anemia Ph I Symic Biomedical Inc....
BioCentury | Jul 11, 2016
Clinical News

SB061: Phase I/II started

...In 2015, Symic and Nordic partnered to develop SB061. Nordic Bioscience A/S , Herlev, Denmark Symic Biomedical Inc....
BioCentury | Apr 7, 2016
Product R&D

Branching out

...With its second compound about to hit the clinic and a fresh influx of money, Symic Biomedical Inc....
...Pharmaceuticals Inc. (NASDAQ:MNTA), Cambridge, Mass. Nordic Bioscience A/S, Herlev, Denmark Purdue University, West Lafayette, Ind. Symic Biomedical Inc....
...Risks Unintended effects of ECM modulation Development status Phase I/II Patents Patented Company; lead investigator Symic Biomedical Inc....
BioCentury | Jan 14, 2016
Company News

Management tracks

...NASDAQ:NLNK) promoted Brian Wiley to chief commercial officer from VP of business development. Inflammatory company Symic Biomedical Inc....
BioCentury | Dec 11, 2015
Company News

Management tracks

...operations. Tripp was director of clinical management at Novo Nordisk A/S (CSE:NVO; NYSE:NVO). Inflammation company Symic Biomedical Inc....
BioCentury | Dec 7, 2015
Financial News

Symic Biomedical completes venture financing

Symic Biomedical Inc. , San Francisco, Calif. Business: Autoimmune, Cardiovascular Date completed: 2015-12-01 Type: Venture financing Raised: $25 million Investors: Lilly Ventures; Alexandria Real Estate Equities; Purdue Research Foundation; Den Danske Forskiningsfond; Mitsui Global Investment; Ally...
BioCentury | Dec 2, 2015
Financial News

Symic raises $25M in series A-2 round

Symic Biomedical Inc. (San Francisco, Calif.) raised $25 million in a series A-2 round led by existing investor Lilly Ventures. New investors Alexandria Real Estate and Purdue Research Foundation also participated, as did existing investors...
BioCentury | Nov 9, 2015
Clinical News

SB-030: Phase I/II started

...about 66 patients undergoing procedures for stenosis or occlusion within the superficial femoral artery (SFA). Symic Biomedical Inc....
BioCentury | Sep 21, 2015
Finance

Hedging in Asia

...Buffalo Grove, Ill. Therapies for cancer and ophthalmic and dermatology disorders 7/14/14 Private placement $35.6 Symic Biomedical Inc....
BioCentury | Jan 5, 2015
Financial News

Symic Biomedical completes venture financing

Symic Biomedical Inc. , San Francisco, Calif. Business: Autoimmune, Cardiovascular Date completed: 2014-11-01 Type: Venture financing Raised: $15 million Investors: Lilly Ventures; Den Danske Forskiningsfond; Mitsui Global Investment; Ally Bridge Group; InCube Ventures; Mission Bay Capital...
Items per page:
1 - 10 of 11
BioCentury | Aug 15, 2016
Finance

Serving returns

...triglycerides. While Ally Bridge's bets in AD and diabetes focus on single assets, portfolio company Symic Biomedical Inc....
...Roche (SIX:ROG; OTCQX:RHHBY), Basel, Switzerland Servier, Neuilly-sur-Seine, France Sorrento Therapeutics Inc. (NASDAQ:SRNE), San Diego, Calif. Symic Biomedical Inc....
...Pieris Pharmaceuticals Inc. (NASDAQ:PIRS) PRS-080, a first-in-class anticalin hepcidin antagonist to treat anemia Ph I Symic Biomedical Inc....
BioCentury | Jul 11, 2016
Clinical News

SB061: Phase I/II started

...In 2015, Symic and Nordic partnered to develop SB061. Nordic Bioscience A/S , Herlev, Denmark Symic Biomedical Inc....
BioCentury | Apr 7, 2016
Product R&D

Branching out

...With its second compound about to hit the clinic and a fresh influx of money, Symic Biomedical Inc....
...Pharmaceuticals Inc. (NASDAQ:MNTA), Cambridge, Mass. Nordic Bioscience A/S, Herlev, Denmark Purdue University, West Lafayette, Ind. Symic Biomedical Inc....
...Risks Unintended effects of ECM modulation Development status Phase I/II Patents Patented Company; lead investigator Symic Biomedical Inc....
BioCentury | Jan 14, 2016
Company News

Management tracks

...NASDAQ:NLNK) promoted Brian Wiley to chief commercial officer from VP of business development. Inflammatory company Symic Biomedical Inc....
BioCentury | Dec 11, 2015
Company News

Management tracks

...operations. Tripp was director of clinical management at Novo Nordisk A/S (CSE:NVO; NYSE:NVO). Inflammation company Symic Biomedical Inc....
BioCentury | Dec 7, 2015
Financial News

Symic Biomedical completes venture financing

Symic Biomedical Inc. , San Francisco, Calif. Business: Autoimmune, Cardiovascular Date completed: 2015-12-01 Type: Venture financing Raised: $25 million Investors: Lilly Ventures; Alexandria Real Estate Equities; Purdue Research Foundation; Den Danske Forskiningsfond; Mitsui Global Investment; Ally...
BioCentury | Dec 2, 2015
Financial News

Symic raises $25M in series A-2 round

Symic Biomedical Inc. (San Francisco, Calif.) raised $25 million in a series A-2 round led by existing investor Lilly Ventures. New investors Alexandria Real Estate and Purdue Research Foundation also participated, as did existing investors...
BioCentury | Nov 9, 2015
Clinical News

SB-030: Phase I/II started

...about 66 patients undergoing procedures for stenosis or occlusion within the superficial femoral artery (SFA). Symic Biomedical Inc....
BioCentury | Sep 21, 2015
Finance

Hedging in Asia

...Buffalo Grove, Ill. Therapies for cancer and ophthalmic and dermatology disorders 7/14/14 Private placement $35.6 Symic Biomedical Inc....
BioCentury | Jan 5, 2015
Financial News

Symic Biomedical completes venture financing

Symic Biomedical Inc. , San Francisco, Calif. Business: Autoimmune, Cardiovascular Date completed: 2014-11-01 Type: Venture financing Raised: $15 million Investors: Lilly Ventures; Den Danske Forskiningsfond; Mitsui Global Investment; Ally Bridge Group; InCube Ventures; Mission Bay Capital...
Items per page:
1 - 10 of 11